← All organizations
Highest phase reached
Phase 1
First clinical trial
Nov 9, 2020Last known activity
Dec 4, 2024
Timeline
No events for the selected filters.
Drugs by trial phase (6 distinct, 6 trials)
Phase 1 (1 own, 0 via acquisition)
Other trials (5 own, 0 via acquisition)
Recent trials (10)
- NCT06919718Lead sponsorN/ADec 4, 2024
- NCT05745870Lead sponsorPhase 1Jan 20, 2023
- NCT05745870Reponsible party - principal investigatorPhase 1Jan 20, 2023
- NCT05619445Lead sponsorN/ADec 1, 2022
- NCT05619445Overall official - principal investigatorN/ADec 1, 2022
- NCT05333939CollaboratorN/AMay 17, 2022
- NCT05109039Reponsible party - principal investigatorN/ASep 27, 2021
- NCT05109039Lead sponsorN/ASep 27, 2021
- NCT04851340Reponsible party - principal investigatorN/ANov 9, 2020
- NCT04851340Lead sponsorN/ANov 9, 2020
Details
- Last known activity
- Dec 4, 2024